
UK Cancer Research Moves Closer to More Precise Trial Design as Pathology Takes a Bigger Role
UK cancer trials may improve if pathology experts are involved earlier in study design, according to a new perspective.
Laboratory research into the biology of cancer and new ways to detect it.

UK cancer trials may improve if pathology experts are involved earlier in study design, according to a new perspective.

NHS will contact 500,000 men for Prostate Progress, a research drive aimed at improving prostate cancer diagnosis and treatment.

A blood test in an NHS trial has flagged gynaecologic cancer risk, adding momentum to UK liquid biopsy research.

MIT study suggests cell membrane lipids can switch on EGFR and drive cancer proliferation, opening a new therapeutic angle.